MedPath

Are Acceptance and Commitment Related to Treatment Response in Chronic Low Back Pain

Completed
Conditions
Low Back Pain
Registration Number
NCT02426970
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

The main objective of this study is to evaluate whether acceptance (measured by the AAQ-II questionnaire) is prognostic of algo-functional changes measured by the Oswestry Disability Index, ODI) at 6 months.

Detailed Description

The secondary objectives are:

A. To search for correlations between the acceptance score (AAQ-II Questionnaire) and scores for coping (CSQ), avoidance (FABQ), understanding (BBQ), anxiety and depression (HADS) and quality of life (SF-12) at baseline.

B. To describe the kinetics of changes in various parameters (acceptance, coping, avoidance, understanding, anxiety and depression, quality of life, ODI) over 6 months.

C. To evaluate the agreement between two methods of questionnaire presentation: Paper collection versus collection by Tablet PC.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • The patient has been informed about the study, and is not opposed to the study
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 6 month of follow-up
  • The subject has chronic back pain that is not post-operative in nature and that has lasted for more than 3 months
  • The subject accepts the re-education curriculum.
Exclusion Criteria
  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to participate
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • The subject has a history of chronic obstructive pulmonary disease, cardiovascular disease, rheumatoid arthritis, lupus, spondylitis or neoplastic disease.
  • Patient currently under psychological treatment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Classification of the patient as a responder or a non responder6 months

The response to treatment will be evaluated by the ODI (Oswestry Disability Index) at 6 months: a patient will be considered as a responder when the absolute change between the score at 6 months and inclusion is at least 10 points (Ostelo RW et al., 2008).

This outcome is a qualitative variable with two options: responder or non-responder. The fact that we define in an apriori fashion who is a responder or not does not mean that we have created multiple outcomes. This is a single outcome.

Acceptation and Action Questionnaire - II (AAQ-II) scoreDay -7 (inclusion)
Secondary Outcome Measures
NameTimeMethod
The Hospital Anxiety and Depression ScaleMonth 6
Average pain over the last 8 days measured via visual analog scale.Month 6
Maximum pain over the last 8 days measured via visual analog scale.Month 6
The SF-12 questionnaireMonth 6
Oswestry Disability IndexMonth 6
The Fear-Avoidance Beliefs QuestionnaireMonth 6
the AAQ-II ScoreMonth 6
Coping Strategies Questionnaire in French (CSQ-F)Month 6
The Back Beliefs QuestionnaireMonth 6

Trial Locations

Locations (2)

CHRU de Montpellier - Hôpital Lapeyronie

🇫🇷

Montpellier, France

CHRU de Nîmes - Hôpital Universitaire Carémeau

🇫🇷

Nîmes Cedex 09, France

© Copyright 2025. All Rights Reserved by MedPath